Interventional, randomised, prospective, monocentric study

Primary objective :

Demonstrate the interest of the homeopathic Protocol to reduce the onset or aggravation of joint pain as a result of the taking of AI compared to conventional care

Secondary objective :

Compare between the two treatment groups:

• Evolution of joint pain
• Evolution of joint stiffness-rate of onset of pain and joint stiffness-delay in onset or aggravation of pain-evolution of the number of painful locations-evolution of the impact of pain on the quality of the sleep-consumption of permitted concomitant treatments (analgesics)
• Evolution of symptoms of hormonal deprivation-adherence to AI treatment
• Tolerance to AI
• Change seen by patients
• Stop rate and switch of AI-rate of recurrence of breast cancer

Describe in patients receiving homeopathic treatment:

• Adherence to homeopathic treatment
• Tolerance to homeopathic treatment
• Group A: Group of patients receiving conventional treatment (drug analgesic class 1) for joint pain + homeopathic treatment
• Group B: Group of patients receiving conventional treatment (drug analgesic class 1) for joint pain

Schedule :

• Inclusions start at: 01/09/2018
• End date of inclusions: 01/09/2020 (duration to possibly adapt in order to obtain the number of required patients)
• End date of follow-up: 01/03/2021
• Study report: 01/09/2021